Enovis announced the expansion of its EMPOWR Revision Knee system to include EMPOWR Cones. The addition of the stackable tibial, femoral, and diaphyseal cones increases options for treating bone defects, creating a comprehensive portfolio to support complex revision needs. The FDA cleared use of the EMPOWR Cones with EMPOWR Revision Knee earlier this year. The EMPOWR Revision Knee system is designed to redefine revision knee arthroplasty through a streamlined yet comprehensive setup which reduces clutter in the operating room while allowing surgeons to fine-tune implant fit to each patient. EMPOWR’s femoral and tibial stackable augments can be used both medially and laterally to minimize excess inventory. The multifunctional instrumentation keeps the surgeon’s back table efficiently organized, streamlining revision procedures.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENOV:
- Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
- Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
- Enovis to Participate in Upcoming Investor Conferences
- Enovis raises FY24 adjusted EPS view to $2.62-$2.77 from $2.52-$2.67
- Enovis reports Q2 adjusted EPS 62c, consensus 59c
Questions or Comments about the article? Write to editor@tipranks.com